United States · Funded startup
Funding summaryUpdated 26 Oct 2026
$121Mraised across 7 rounds since 2009, from 7 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
From a historical funding record
Reported by prnewswire.comSEC filing: $14M sold, first sale Mar 2012
No investor was named in the report.
Reported by fiercebiotech.comSEC filing: $16M sold, first sale Sept 2010
No investor was named in the report.
Reported by sec.govSEC filing: $16M sold, first sale Sept 2010
Reported by onbiovc.comSEC filing: $12M sold, first sale Oct 2009
No investor was named in the report.
From a historical funding recordSEC filing: $12M sold, first sale Oct 2009
From the SEC filings it signed: 2 on the team.
On the board, as filediEric BednarskiMartin EdwardsRichard KollenderRichard Levy
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Quaker Partners
MVM Life Science Partners
Foresite CapitalNovo Holdings A/S
Novo Holdings
Square 1 Bank
Oxford Finance LLC
MarkerMissing a round, or an investor who was in one? Tell us.
Tarsa Therapeutics's investors include Quaker Partners, MVM Life Science Partners, Foresite Capital, Novo Holdings A/S and Novo Holdings, and 3 more on record.
Tarsa Therapeutics has raised $121M across 7 rounds since 2009.
Tarsa Therapeutics's most recent round was a Debt of $10M in Aug 2014.
Tarsa Therapeutics's largest round on record is $28M (Series B), in Mar 2012.
Tarsa Therapeutics's first round on record, in Jan 2010, was backed by Novo Holdings, Quaker Partners and MVM Life Science Partners.
Tarsa Therapeutics's latest named round is a Debt, in Aug 2014.
Tarsa Therapeutics is based in the United States.
In the same sector, and raised in the last eighteen months.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.
United States · 
